And what the heck is bio-convergence, anyway? It's where biology, engineering and artificial intelligence converge.
Fluidigm Corporation (NASDAQ:LAB), a company specializing in microfluidic systems for the life sciences industry with a market capitalization of $458 million, has seen its stock price touch a 52-week ...
El Mundo on MSN3 天
A 'Lab Twin' to Study the Effectiveness of Cancer TreatmentsA device developed by the Institute of Bioengineering of Catalonia and the Research Institute of Hospital del Mar allows replicating tumors and their environment to analyze the response to therapies.
CAMBRIDGE, MA AND PITTSBURGH, PA / ACCESSWIRE / 10, 2025 / Next Gen Diagnostics (NGD), a pioneer in the development of machine learning models for whol ...
The University of Oulu is at the forefront of developing cutting-edge biosensor technology that could revolutionize the early diagnosis and treatment of diseases.
The Micro Immune Response On chip (MIRO) allows tumours and their environment to be replicated in order to understand their ...
In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, ...
A team led by the Institute for Bioengineering of Catalonia (IBEC) and the Hospital del Mar Research Institute has developed ...
Cubit Diagnostics announced on Tuesday that it has been awarded $2.6 million by the National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) Tech program. The funding will enable the ...
The Micropump Market is driven by the increasing demand for precise fluid handling solutions in industries such as healthcare, pharmaceuticals, and b ...
Dr. Arum Han, the Texas Instruments Professor in the Department of Electrical and Computer Engineering, and his lab, created a technology named NOVAsort (Next-generation Opto-Volume-based Accurate ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果